Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Get Ready for More Acquisitions by Gilead Sciences
Motley Fool
Wed, 08/30/17 - 09:36 am
Tags:
Gilead Sciences, M&A, Kite Pharma, Ziopharm
AIDS activists urge N.Y. attorney general to probe Gilead for antitrust violations
Stat
Tue, 08/29/17 - 09:15 pm
Tags:
Gilead Sciences, Truvada, antitrust, AIDS, HIV
How will Gilead price CAR-T? With Kite buy, the top biotech joins Novartis in spotlight
Fierce Pharma
Tue, 08/29/17 - 09:07 pm
Tags:
Gilead Sciences, Kite Pharma, CAR-T, drug pricing, M&A
Here's What Else Gilead Sciences Gets by Buying Kite Pharma
Motley Fool
Tue, 08/29/17 - 10:01 am
Tags:
Gilead Sciences, Kite Pharma, M&A, CAR-T, TCR-targeted drugs
To Be More Than a Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles
Xconomy
Tue, 08/29/17 - 09:40 am
Tags:
Gilead Sciences, Kite Pharma, M&A, CAR-T
5 Reasons The Gilead-Kite Acquisition Might Work
Seeking Alpha
Mon, 08/28/17 - 10:47 pm
Tags:
Gilead Sciences, M&A, Kite Pharma, CAR-T
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Motley Fool
Mon, 08/28/17 - 10:26 pm
Tags:
Bluebird Bio, Juno Therapeutics, Gilead Sciences, Kite Pharma, CAR-T, M&A
Gilead agrees to buy Kite Pharma, leaping into CAR-T cancer therapy
Stat
Mon, 08/28/17 - 10:04 am
Tags:
Gilead Sciences, Kite Pharma, CAR-T, M&A, axi-cel
Why Gilead Sciences Might Not Make an Oncology Acquisition
Motley Fool
Tue, 08/15/17 - 08:16 pm
Tags:
Gilead Sciences, M&A, oncology
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
Tags:
biotech, M&A, JNJ, Actelion, Takeda, Ariad Pharmaceuticals, Gilead Sciences, Pfizer, Amgen
Gilead circles February 12 on its calendar as D-day for its HIV franchise
Endpoints
Fri, 08/11/17 - 10:56 am
Tags:
Gilead Sciences, HIV, FTC/TAF, FDA
These 3 Biotechs Just Crushed Analyst Expectations
Motley Fool
Mon, 08/7/17 - 01:36 pm
Tags:
biotech, earnings, Sarepta Therapeutics, Biogen, Gilead Sciences
AbbVie’s new, cheaper hepatitis C drug could launch the drug world’s own Hunger Games
Marketwatch
Sun, 08/6/17 - 09:48 pm
Tags:
AbbVie, hepatitis C, Mavyret, Gilead Sciences, Merck
Is AbbVie About to Deliver a Blow to Gilead Sciences' Guidance?
Motley Fool
Sat, 08/5/17 - 09:44 am
Tags:
AbbVie, Gilead Sciences, hepatitis C, Mavyret
Gilead Could Be Making An Acquisition — But It's Not What You Think
Investors Business Daily
Fri, 08/4/17 - 11:56 am
Tags:
Gilead Sciences, M&A, United Therapeutics, GSK, Novartis
5 Things Gilead Sciences' Q2 Earnings Numbers Didn't Tell You
Motley Fool
Mon, 07/31/17 - 09:59 pm
Tags:
Gilead Sciences, earnings, hepatitis C, HIV, M&A
Gilead Sciences Has 3 Available Options, but Only 1 Makes Sense
Motley Fool
Thu, 07/27/17 - 09:47 am
Tags:
Gilead Sciences, AbbVie, hepatitis C, reorganization
J&J reports positive results for HIV regimen
BioPharma Dive
Wed, 07/26/17 - 11:21 am
Tags:
JNJ, HIV, Gilead Sciences, Darunavir
Gilead's combo shows no resistance in HIV
BioPharma Dive
Wed, 07/26/17 - 12:08 am
Tags:
HIV, Gilead Sciences, emtricitabine/tenofovir alafenamide
Gilead details its case for a new HIV flagship triple, with megablockbuster potential
Endpoints
Mon, 07/24/17 - 10:43 am
Tags:
Gilead Sciences, HIV, bictegravir, FTC/TAF

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.